Autotransfusion Systems Market by Type and Geography - Forecast and Analysis 2022-2026

The autotransfusion systems market share is expected to increase by USD 292.12 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.67%.

This autotransfusion systems market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers autotransfusion systems market segmentation by type (autotransfusion products and autotransfusion accessories) and geography (North America, Europe, Asia, and Rest of World (ROW)). The autotransfusion systems market report also offers information on several market vendors, including Becton Dickinson and Co., Braile Biomedica, Fresenius Kabi AG, Gen World Medical Devices, Getinge AB, Haemonetics Corp., Informa Plc, LivaNova Plc, Medtronic Plc, Redax Spa, SARSTEDT AG and Co. KG, Teleflex Inc., and Zimmer Biomet Holdings Inc. among others.

What will the Autotransfusion Systems Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Autotransfusion Systems Market Size for the Forecast Period and Other Important Statistics

 

Autotransfusion Systems Market: Key Drivers, Trends, and Challenges

The rising number of cardiac and orthopedic surgeries is notably driving the autotransfusion systems market growth, although factors such as high costs associated with autotransfusion may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the autotransfusion systems industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Autotransfusion Systems Market Driver

The rising number of cardiac and orthopedic surgeries is one of the key drivers supporting the autotransfusion systems market growth. The rising prevalence and incidence of orthopedic-related problems have increased across the globe. Arthritis is one of the major healthcare burdens that affect the population globally. The CDC stated that 54.4 million adults were diagnosed with arthritis during 2015-2020. Surgical options, such as arthroscopy and joint replacements, are performed by surgeons to help patients to get relief from pain. Patients suffering from anemia, sickle cell disease, and hemophilia require a blood transfusion during intraoperative or postoperative procedures. Allogeneic blood transfusion is mainly performed during the surgeries, which leads to a significant chance of developing various bacterial and viral infections. To avoid the risk of infections, autologous transfusions are performed during major surgical procedures. Thus, an increase in various surgical procedures across the globe is primarily driving the growth of the global autotransfusion devices market.

Key Autotransfusion Systems Market Trend

Growing awareness about risks related to allogeneic blood transfusion is another factor supporting the autotransfusion systems market growth. An autologous blood program awareness that is conducted in hospitals helps doctors and patients to understand the benefits of autologous transfusion. For instance, Children's National Hospital in the US offers Directed Donor Program, which allows the patient as well as the patient's family and friends to donate blood during their hospital stay if required. Similarly, in the UK, the Cell Salvage Action Group Business Case, in 2007, developed a strategy program to enhance the usage of intraoperative cell salvage by reducing allogeneic blood transfusion. The organization recommended budgetary savings to perform an autologous blood transfusion. This type of strategy and initiative will increase the demand for the autotransfusion process, which will drive the growth of the global autotransfusion systems market during the forecast period.

Key Autotransfusion Systems Market Challenge

The high costs associated with autotransfusion is one of the factors hindering the autotransfusion systems market growth. The average cost of the most common type of heart surgery is generally ranging from $25,000 to $250,000, depending on the type of surgery, surgeons involved, and the facility where the surgery is carried out. The increasing need for the maintenance of devices and their accessories creates a burden on hospital expenditure. Increasing hospital expenditure and advanced infrastructure help healthcare providers to purchase and maintain autotransfusion devices for the autotransfusion process. The high cost of surgical procedures, the maintenance of autotransfusion systems, and the cost and time required for the autotransfusion procedure can suppress the adoption of the autotransfusion process and thereby hamper the growth of the global autotransfusion systems market to a certain extent.

This autotransfusion systems market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global autotransfusion systems market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the autotransfusion systems market during the forecast period.

Who are the Major Autotransfusion Systems Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Becton Dickinson and Co.
• Braile Biomedica
• Fresenius Kabi AG
• Gen World Medical Devices
• Getinge AB
• Haemonetics Corp.
• Informa Plc
• LivaNova Plc
• Medtronic Plc
• Redax Spa
• SARSTEDT AG and Co. KG
• Teleflex Inc.
• Zimmer Biomet Holdings Inc.

 

This statistical study of the autotransfusion systems market encompasses successful business strategies deployed by the key vendors. The autotransfusion systems market is fragmented and the vendors are deploying growth strategies such as product launches to compete in the market.

Product Insights and News

• Informa Plc is a public company headquartered in UK. It is a global company generating $2,266.83 million in revenues and has around 10,945 employees. Its revenue from the global autotransfusion systems market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company.
• Informa Plc - The company offers Lukay disposable autotransfusion system which is a closed blood recovery system used post-operatively to collect, filter, allow for reinfusion of autologous blood and the subsequent drainage.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The autotransfusion systems market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Autotransfusion Systems Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the autotransfusion systems market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Autotransfusion Systems Market?

For more insights on the market share of various regions Request for a FREE sample now!

44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for autotransfusion systems market in North America. Market growth in this region will be faster than the growth of the market in other regions.

The increasing prevalence of cardiac and orthopedic surgeries will facilitate the autotransfusion systems market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the COVID-19 pandemic affected North America. The pandemic led to an increased number of in-patients. However, with the advancement of autotransfusion technologies and the rising demand for improved healthcare infrastructure in the region, the demand for autotransfusion systems is expected to drive market growth during the forecast period.

What are the Revenue-generating Type Segments in the Autotransfusion Systems Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The autotransfusion systems market share growth by the autotransfusion products segment will be significant during the forecast period. Autotransfusion products constitute the largest segment of the global autotransfusion systems market. These products are primarily used for the autotransfusion process during intraoperative and postoperative procedures. These products are highly advanced with an effective design for providing autologous blood transfusion during surgical procedures. The increasing number of patients undergoing cardiac and orthopedic surgeries and for blood volume replacement are the major factors that are contributing to the growing need for autotransfusion in postoperative settings. Such factors are expected to positively impact market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the autotransfusion systems market size and actionable market insights on post COVID-19 impact on each segment.

 

Autotransfusion Systems Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 4.67%
Market growth 2022-2026	$ 292.12 million
Market structure	Fragmented
YoY growth (%)	4.42
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 44%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Becton Dickinson and Co., Braile Biomedica, Fresenius Kabi AG, Gen World Medical Devices, Getinge AB, Haemonetics Corp., Informa Plc, LivaNova Plc, Medtronic Plc, Redax Spa, SARSTEDT AG and Co. KG, Teleflex Inc., and Zimmer Biomet Holdings Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Autotransfusion Systems Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive autotransfusion systems market growth during the next five years
• Precise estimation of the autotransfusion systems market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the autotransfusion systems industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of autotransfusion systems market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch